共 50 条
A Case Report of Dapagliflozin-Induced Nodular Vasculitis
被引:0
|作者:
Kocabas, Muhammet
[1
]
Yarar, Zeliha
[1
]
Cordan, Ilker
[2
]
Can, Mustafa
[1
]
Caliskan Burgucu, Hatice
[1
]
Aydemir, Harun
[3
]
Karakose, Melia
[1
]
Kulaksizoglu, Mustafa
[1
]
Karakurt, Feridun
[1
]
机构:
[1] Necmettin Erbakan Univ, Meram Fac Med, Dept Endocrinol & Metab, Konya, Turkey
[2] Edirne Sultan 1 Murat State Hosp, Clin Endocrinol & Metab, Edirne, Turkey
[3] Necmettin Erbakan Univ, Meram Fac Med, Dept Rheumatol, Konya, Turkey
关键词:
Nodular vasculitis;
dapagliflozin;
antinuclear antibodies;
sodium-glucose cotransporter-2 inhibitors;
diabetes mellitus;
SGLT2;
INHIBITORS;
DIAGNOSIS;
D O I:
10.25179/tjem.2020-80188
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Nodular vasculitis (NV), first described by Montgomery in 1945 for erythema induratum-like lesions, is a rare form of panniculitis that is particularly localized on the calves. Characterized by plaques and erythematous nodules, NV may often show ulceration and draining. It is known as a reactive disease associated with many causative factors. Several NV cases due to infectious or non-infectious causative factors have been reported, but no case of NV due to sodium-glucose cotransporter-2 inhibitors (SGLT2i) has yet been reported. In this case report, we presented a case diagnosed with NV, who presented with tender, erythematous, eroded plaques with hemorrhagic-purulent discharge on both legs during treatment with dapagliflozin (an SGLT2i).
引用
收藏
页码:129 / 132
页数:4
相关论文